Name: Bloomberg Deals 7/8/2026
Uploaded: 2026-07-08T20:36:16+00:00
Duration: 2074 s

Speakers

Krishna Veeraraghavan — Global Co-Head of M&A, Paul Weiss

Scarlet Fu — Anchor, Bloomberg Television

Ryan Gould — Head of Content, Blockworks

Dani Burger — Anchor, Bloomberg Television

Liana Baker — Reporter / Correspondent

Grace Lee — Partner & Managing Director, Alix Partners

Annmarie Hordern — Reporter, Bloomberg

Summary

The episode covers AI chip startup SambaNova's $1 billion raise, Broadcom's $30 billion deal with Apple, Bank of America's credit line to OpenAI, and the upcoming SK Hynix U.S. listing. M&A advisor Krishna Veeraraghavan highlights a booming biotech dealmaking environment, while media expert Grace Lee discusses scale-driven consolidation, linear TV's decline, and sports rights valuations. Geopolitical developments around Iran and a Lockheed Martin expansion are also featured.

SambaNova raises $1B at $11B valuation for AI inference chips
Broadcom stock rises on $30B Apple chip partnership announcement
BofA extends credit to OpenAI aiming for IPO underwriting role
SK Hynix's $28B Nasdaq ADR listing oversubscribed amid AI memory demand
Biotech M&A surges with XBI up 80% YTD; patent cliff drives deals
Media consolidation accelerates as linear TV declines and sports rights premium grows
Trump touts Lockheed Martin European weapon facility, views oil market as glutted
US-Iran tensions inject volatility while Strait of Hormuz transit risk persists

Ideas

Ryan Gould Head of Content, Blockworks 2:11

Apple partnership boosts Broadcom shares

Broadcom's $30 billion chip partnership with Apple signals alignment with the administration's Made in America agenda and extends a long-standing supply relationship. Shares rose on the news and investors should be pleased with the development.

Scarlet Fu Anchor, Bloomberg Television 4:39

AI memory demand and US listing catalyst

SK Hynix is capitalizing on tsunami of demand for high bandwidth memory from the AI boom. Its U.S. listing is multiple times oversubscribed, opens a new fundraising channel for building new chip plants, and Baillie Gifford and other long-only funds have indicated strong interest, supporting a long-term positive outlook.

Krishna Veeraraghavan Global Co-Head of M&A, Paul Weiss 7:27

Biotech M&A and equity rally accelerating

Biotech M&A is booming in 2026, with more deals over $1 billion than all of 2025 combined, driven by large pharma facing $300 billion in patent cliffs by 2030 and being rewarded for acquisitions. A new class of mid-cap buyers has emerged, private transactions are surging, and equity markets have resurged (XBI up 80% YTD). Regulatory fears have flipped, creating a virtuous cycle of capital flowing into biotech.

Dani Burger Anchor, Bloomberg Television 28:14

Lockheed Martin expands European defense output

President Trump announced Lockheed Martin will establish a new weapon-making facility in Europe and aims to quadruple output, signaling a significant expansion in European defense manufacturing.

This Bloomberg Markets video, published July 08, 2026, features Ryan Gould, Scarlet Fu, Krishna Veeraraghavan, Dani Burger discussing AVGO, 000660.KS, XBI, LMT. 4 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Ryan Gould, Scarlet Fu, Krishna Veeraraghavan, Dani Burger · Tickers: AVGO, 000660.KS, XBI, LMT

Bloomberg Deals 7/8/2026

Summary

Ideas

Up Next